Trimega's New Substance Abuse Testing Laboratory in Manchester to Alleviate Impact of Forensic Science Service Closure

By Trimega Laboratories, PRNE
Thursday, February 17, 2011

Trimega Invests GBP1 Million in New Lab

MANCHESTER, England, February 18, 2011 - Trimega Laboratories, the leading substance abuse testing company, has
opened a new lab in Manchester which will assist the government with its
forensic toxicology workload in the wake of the closure of the Forensic
Science Service (FSS).

Trimega Laboratories has invested GBP1 million in the state-of-the-art,
1,900 square-foot laboratory, which is located in the Hexagon Tower in
Manchester.

The impact of the FSS' closure was highlighted this month when it was
revealed that the police had been told to refrigerate samples from drink
driving suspects due to a lack of resources to process them.

Trimega's new facility includes world-class substance abuse testing
technology. The company specialises in hair testing, a ten year old
technology that can detect longer patterns of alcohol and drug consumption
than traditional blood and urine methods, which only register consumption of
the previous few days for drug analysis.

One of the key applications of hair testing is the protection of children
from parents and guardians with alcohol and drug dependencies. There is an
estimated 20,000 hair alcohol and drug tests requested in UK child custody
cases each year.

The Forensic Science Service considers the 'Gold Standard' for reliable
drug detection to be laboratory based gas chromatography combined with mass
spectrometry (GC/MS), a test that is possible on hair. Trimega's new
laboratory uses the latest mass spectrometry techniques to accurately
determine drug usage to very small detectable levels including High
Performance Liquid Chromatography tandem mass spectrometry (HPLC/MS/MS) and
the gas chromatographic equivalent (GC/MS/MS). These techniques are often
referred to as the 'Platinum Standard' when compared with traditional GC/MS
analysis.

Much of the FSS' specialist toxicology work was sent to France and took
weeks to complete. Trimega's technology and its location in the UK enable it
to complete toxicology analysis in as little as 2-10 days, thereby reducing
the time to provide evidence in criminal cases.

Avi Lasarow, CEO of Trimega Laboratories, said: "The closure of the FSS
opens up opportunities for private companies in the forensic toxicology
sector and we are delighted to launch our own high-tech laboratory in
Manchester to help the government manage its workload of cases. Getting
analysis done by the private sector faster than before will not only help
reduce crime but also save the government considerable sums in unnecessary
costs incurred by court timetable delays."

Trimega currently employs 42 people, with 10 based at the Hexagon Tower.
The company plans to hire a further 10 staff this year in Manchester.

The lab includes a suite from where Trimega will provide complimentary
training for solicitors, barristers and police officers who wish to learn
more about the technicalities of hair testing within the legal process both
for family and criminal law.

Sir Richard Leese, Leader of Manchester City Council, officially opened
Trimega's new laboratory on 18 February at an event that was also attended by
the High Commissioner of South Africa in the UK, Dr. Zola Skweyiya, and the
renowned global experts on hair testing technology, Professor Fritz Pragst
and Dr. Hans Sachs, former President of the Society of Hair Testing (SOHT)
and a leading expert in this field whose expertise has been called on for
many high profile legal matters, including the Harold Shipman case.

Notes to Editors

About Trimega Laboratories

Established in London in 2005, Trimega Laboratories (
www.trimegalabs.co.uk) has developed a range of innovative techniques
for testing substances of abuse. Its core business is laboratory-based
analysis of hair samples that provides accurate historical records of any
alcohol or drugs dependency over a one to 12 month period. In the UK its
clients include: family law specialists, social services, regulatory bodies,
and professional nursing and pilot organisations. Trimega also works with
courts directly.

Other services offered by Trimega Laboratories include: Roadside
Drugalyzer Testing for law enforcement, Hair Steroid Testing for athletes,
and most recently, Hair Benzodiazepines Testing. Trimega is ISO 14001
certified for environmental management and is also an Investor In People.
Trimega Laboratories won the title of Best Use of Technology in the 2008
Barclays-sponsored Startups Awards and has been on the shortlist for the
National Business Awards three years running. It was also one of 25 companies
to represent the UK in the 2010 European Business Awards.

Trimega was also responsible for the creation of a Hair Strand Scientific
Advisory Board. Its purpose is to analyse the fast growing database of
information created from the 10,000 hair alcohol tests and 7,000 hair drug
tests carried out in the UK each year, of which Trimega is responsible for
around 40 per cent. The findings of the Board are shared with the Society of
Hair Testing (SoHT) which, as a peer review organisation, will assist it in
future decisions - particularly those relating to the setting of universal
standards/guidelines. The Board consists of:

Dr. Hans Sachs - past President of the SoHT and the lead scientist in the
Harold Shipman case;

Professor Fritz Pragst - award-winning forensic toxicologist and founding
father of Hair Alcohol Testing; and

Dr. Silke Suese - member of SoHT and Laboratory Director of Trimega

Drogencheck GmbH laboratory.

Trimega is a Charter Member of The Duke of Edinburgh's Award.

A picture accompanying this release is available through the PA
Photowire. It can be downloaded from www.pa-mediapoint.press.net or
viewed at www.mediapoint.press.net or www.prnewswire.co.uk.

For additional information: Cubitt Consulting, Simon Barker, Partner, +44(0)20-7367-5119 / simon.barker at cubitt.com; Russell Lindsey, Associate, +44(0)20-7367-5141 / russell.lindsey at cubitt.com

YOUR VIEW POINT
NAME : (REQUIRED)
MAIL : (REQUIRED)
will not be displayed
WEBSITE : (OPTIONAL)
YOUR
COMMENT :